Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events.
about
Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in TanzaniaEvaluation of an immunoassay for determination of plasma efavirenz concentrations in resource-limited settings.Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program.Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa.Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, KenyaEarly mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysisBaseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings.Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa.Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapyAntiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?Anemia and Red Blood Cell Abnormalities in HIV-Infected and HIV-Exposed Breastfed Infants: A Secondary Analysis of the Kisumu Breastfeeding Study.Incidence of Severe Neutropenia in HIV-Infected People Starting Antiretroviral Therapy in West Africa.Prevalence, severity, and related factors of anemia in HIV/AIDS patients.Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART RegimenSocial factors associated with the knowledge about HIV of the immigrants from China, Latin America, the Maghreb and Senegal in the Basque Country (Spain).Anaemia in HIV-infected pregnant women receiving triple antiretroviral combination therapy for prevention of mother-to-child transmission: a secondary analysis of the Kisumu breastfeeding study (KiBS).Brief Report: Late Efavirenz-Induced Ataxia and Encephalopathy: A Case Series.Safety of zidovudine dose reduction in treatment-naïve HIV infected patients. A randomized controlled study (MiniZID).Records linkage of electronic databases for the assessment of adverse effects of antiretroviral therapy in sub-Saharan Africa.Measuring perceived stigma in female sex workers in Chennai, India.High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study
P2860
Q28481272-91DE273F-19C7-4897-BF6B-9CBC9F0C1E79Q33725030-698E37A8-8F48-4D94-A171-63AFF522BAE5Q33782796-084BB8DD-B45F-485D-B76A-C9A37B8CA74FQ34019508-12C14085-F66E-465E-B515-94C0A5CACFFCQ34087372-17037EAC-29AF-45C5-A624-277BD51C4791Q34119037-CAE1CE9C-A157-44B6-A712-2651D094C0DBQ34347685-C5F19E42-2545-438F-835E-0B149D77999DQ34988904-066D35DB-C1F5-46C6-A655-6B331E7AFC30Q35031969-65A81C11-9BBE-48C4-95A0-1D42017E8B95Q35164547-3DF94594-904A-4563-A014-6A9829C7A15CQ35770848-D27C7983-16F3-4544-809A-D123DBC7B264Q35830556-A28AE72D-4446-4F23-9398-FC599D21FD21Q36259878-E9ADF908-C4D5-4014-BF55-DC1012E68434Q36474615-CEE49645-7B72-405B-A9ED-A52097FC6CE2Q37166538-9B91F61D-571E-423F-8106-C5AE9B0E8EE8Q39405258-67768B74-8300-4E5A-B4DA-0A17F2A2BAE5Q40073926-C24B5E77-411E-4508-8E55-7FD38C237E5FQ40207726-02D283DE-502B-476B-ADB8-3D41CA6B49C4Q41007911-E7A29573-2B82-4870-873B-F371E495A706Q43411739-72279233-5A4E-4F16-B0B9-B47BA693A176Q51508721-B68B3CE8-DC34-4697-AA8C-CE172B0AFB70Q56829831-71822D02-3A4D-4FEF-8D97-D7BE50218CAC
P2860
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiretroviral therapy using z ...... erability and clinical events.
@en
Antiretroviral therapy using z ...... erability and clinical events.
@nl
type
label
Antiretroviral therapy using z ...... erability and clinical events.
@en
Antiretroviral therapy using z ...... erability and clinical events.
@nl
prefLabel
Antiretroviral therapy using z ...... erability and clinical events.
@en
Antiretroviral therapy using z ...... erability and clinical events.
@nl
P2093
P2860
P50
P1433
P1476
Antiretroviral therapy using z ...... erability and clinical events.
@en
P2093
Alison D Grant
Chloe L Thio
Craig Innes
Mark S Sulkowski
P2860
P356
10.1097/QAD.0B013E3282F2306E
P407
P50
P577
2008-01-01T00:00:00Z